Your browser doesn't support javascript.
loading
Risk of diabetes after para-aortic radiation for testicular cancer.
Groot, Harmke J; Gietema, Jourik A; Aleman, Berthe M P; Incrocci, Luca; de Wit, Ronald; Witjes, J Alfred; Groenewegen, Gerard; de Brouwer, Peter; Meijer, Otto W M; Hulshof, Maarten C C M; van den Berg, Hetty A; Smilde, Tineke J; Vanneste, Ben G L; Aarts, Maureen J; van den Bergh, Alphonsus C M; Kerst, J Martijn; van den Belt-Dusebout, Alexandra W; Lubberts, Sjoukje; Józwiak, Katarzina; Horenblas, Simon; van Leeuwen, Flora E; Schaapveld, Michael.
Afiliación
  • Groot HJ; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Gietema JA; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
  • Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Incrocci L; Department of Radiation Oncology, Erasmus Medical Center Cancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
  • de Wit R; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
  • Witjes JA; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
  • Groenewegen G; Department of Medical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • de Brouwer P; Department of Radiation Oncology, Dr. Bernard Verbeeten Institute, Brugstraat 10, 5042 SB, Tilburg, The Netherlands.
  • Meijer OWM; Department of Radiation Oncology, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Hulshof MCCM; Department of Radiation Oncology, Amsterdam Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • van den Berg HA; Department of Radiotherapy, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven Eindhoven, The Netherlands.
  • Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, Henri Dunantstraat 1, 5223 GZ, 's-Hertogenbosch, The Netherlands.
  • Vanneste BGL; Department of Radiotherapy, MAASTRO-clinic, Dr. Tanslaan 12, 6229 ET, Maastricht, The Netherlands.
  • Aarts MJ; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
  • van den Bergh ACM; Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
  • Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • van den Belt-Dusebout AW; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Lubberts S; Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
  • Józwiak K; Department of Biostatistics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Horenblas S; Department of Urology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. m.schaapveld@nki.nl.
Br J Cancer ; 119(7): 901-907, 2018 10.
Article en En | MEDLINE | ID: mdl-30297773
ABSTRACT

BACKGROUND:

While the risk of diabetes is increased following radiation exposure to the pancreas among childhood cancer survivors, its association among testicular cancer (TC) survivors has not been investigated.

METHODS:

Diabetes risk was studied in 2998 1-year TC survivors treated before 50 years of age with orchidectomy with/without radiotherapy between 1976 and 2007. Diabetes incidence was compared with general population rates. Treatment-specific risk of diabetes was assessed using a case-cohort design.

RESULTS:

With a median follow-up of 13.4 years, 161 TC survivors were diagnosed with diabetes. Diabetes risk was not increased compared to general population rates (standardised incidence ratios (SIR) 0.9; 95% confidence interval (95% CI) 0.7-1.1). Adjusted for age, para-aortic radiotherapy was associated with a 1.66-fold (95% CI 1.05-2.62) increased diabetes risk compared to no radiotherapy. The excess hazard increased with 0.31 with every 10 Gy increase in the prescribed radiation dose (95% CI 0.11-0.51, P = 0.003, adjusted for age and BMI); restricted to irradiated patients the excess hazard increased with 0.33 (95% CI -0.14 to 0.81, P = 0.169) with every 10 Gy increase in radiation dose.

CONCLUSION:

Compared to surgery only, para-aortic irradiation is associated with increased diabetes risk among TC survivors.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Radioterapia / Neoplasias Testiculares / Diabetes Mellitus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Male Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Radioterapia / Neoplasias Testiculares / Diabetes Mellitus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Male Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos